Patents by Inventor Ulrich Suchner

Ulrich Suchner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition comprising a combination of DHA and EPA for administration prior to commencement of chemotherapy
    Patent number: 9675574
    Abstract: The invention relates to a composition comprising a combination of the omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). The composition can be used for enhancing the activity of chemotherapy or radiotherapy and/or in the prevention or reduction of side effects caused by the chemotherapy or radiotherapy in a patient ill with cancer, the composition being intended for administration to the patient prior to the commencement of a cycle of chemotherapy or radiotherapy.
    Type: Grant
    Filed: March 31, 2015
    Date of Patent: June 13, 2017
    Assignee: Fresenius Kabi Deutschland GmbH
    Inventors: Ewald Schlotzer, Barbara Krampitz, Ulrich Suchner
  • COMPOSITION COMPRISING A COMBINATION OF DHA AND EPA FOR ADMINISTRATION PRIOR TO COMMENCEMENT OF CHEMOTHERAPY
    Publication number: 20150297549
    Abstract: The invention relates to a composition comprising a combination of the omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). The composition can be used for enhancing the activity of chemotherapy or radiotherapy and/or in the prevention or reduction of side effects caused by the chemotherapy or radiotherapy in a patient ill with cancer, the composition being intended for administration to the patient prior to the commencement of a cycle of chemotherapy or radiotherapy.
    Type: Application
    Filed: March 31, 2015
    Publication date: October 22, 2015
    Inventors: Ewald Schlotzer, Barbara Krampitz, Ulrich Suchner
  • MEDICAMENT COMPRISING AT LEAST ONE OMEGA-3 POLYUNSATURATED FATTY ACID
    Publication number: 20150272916
    Abstract: A medicament comprising a therapeutically effective amount of at least one omega-3 polyunsaturated fatty acid for use in the reduction and prevention of post-ischemic damages in patients undergoing elective surgery.
    Type: Application
    Filed: November 6, 2013
    Publication date: October 1, 2015
    Inventors: Heidi Schuster, Ewald Schlotzer, Ulrich Suchner, Mette Berger, Luc Tappy, Lucas Liaudet, Rene Chiolero
  • COMPOSITION COMPRISING A COMBINATION OF DHA AND EPA FOR ADMINISTRATION PRIOR TO COMMENCEMENT OF CHEMOTHERAPY
    Publication number: 20130197087
    Abstract: The invention relates to a composition comprising a combination of the omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). The composition can be used for enhancing the activity of chemotherapy or radiotherapy and/or in the prevention or reduction of side effects caused by the chemotherapy or radiotherapy in a patient ill with cancer, the composition being intended for administration to the patient prior to the commencement of a cycle of chemotherapy or radiotherapy.
    Type: Application
    Filed: August 26, 2011
    Publication date: August 1, 2013
    Applicant: Fresenius Kabi Deutschland GmbH
    Inventors: Ewald Schlotzer, Barbara Krampitz, Ulrich Suchner
  • Supplement to be enterally administered for parenteral nutrition or partial enteral/oral nutrition of the critically ill, the chronically ill and people with malnutrition
    Patent number: 7947303
    Abstract: A supplement to be administered enterally to maintain or restore the intestinal intestinal barrier of the critically or chronically ill and people with malnutrition is described. This contains as solution, in each case based on a daily dose, a) glutamine and/or glutamine precursors in an amount in the range from 15 to 70 g, b) at least two representatives from the group of substances having antioxidant activity, and c) short-chain fatty acids and/or precursors of short-chain fatty acids in an amount of from 0.5 to 10 g.
    Type: Grant
    Filed: November 14, 2001
    Date of Patent: May 24, 2011
    Assignee: Fresenius Kabi Deutschland GmbH
    Inventors: Barbara Kessler, Angelika Riedel, Ulrich Suchner
  • Supplement to be enternally administered for parenteral nutrition or partial enteral/oral nurtrition of the critically ill, the chronically ill and people with malnutrition
    Publication number: 20040097404
    Abstract: Supplement to be enterally administered for parenteral nutrition or partial enteral/oral nutrition of the critically ill, the chronically ill and people with malnutrition
    Type: Application
    Filed: November 20, 2003
    Publication date: May 20, 2004
    Inventors: Barbara Kessler, Angelika Riedel, Ulrich Suchner